158
Views
6
CrossRef citations to date
0
Altmetric
Research Article

In silico mapping of polymorphic miRNA–mRNA interactions in autoimmune thyroid diseases

Pages 327-333 | Received 15 Nov 2013, Accepted 09 Feb 2014, Published online: 10 Mar 2014
 

Abstract

MicroRNAs (miRNAs) are important regulators of gene expression and translation. The genetic variants altering miRNA targets have been associated with many diseases. Here we systematically mapped the human genetic polymorphisms that may affect miRNA–mRNA interactions in the autoimmune thyroid disease (AITD) pathway. We also mapped the polymorphic miRNA target sites in the genes that have been linked to AITDs or other thyroid-related diseases/phenotypes in genome-wide association studies (GWAS). These genetic polymorphisms may potentially contribute to the pathogenesis of AITDs and other thyroid diseases. The polymorphic miRNA–mRNA interactions we mapped in the AITD pathway and the GWAS-informed thyroid disease loci may provide insights into the possible miRNA-mediated molecular mechanisms through which genetic variants assert their influences on thyroid diseases and phenotypes.

Notes

1Photoactivatable-ribonucleoside-enhanced crosslinking and Immunoprecipitation.

2High-throughput sequencing of RNA isolated by crosslinking immunoprecipitation.

3Crosslinking, ligation and sequencing of hybrids.

4National Human Genome Research Institute.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.